Australia markets close in 1 hour 51 minutes

GSK plc (GSK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
44.14-0.01 (-0.02%)
At close: 04:00PM EDT
44.13 -0.01 (-0.02%)
After hours: 07:28PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 90.19B
Enterprise value 107.37B
Trailing P/E 16.15
Forward P/E 11.20
PEG ratio (5-yr expected) 1.18
Price/sales (ttm)2.35
Price/book (mrq)5.18
Enterprise value/revenue 3.49
Enterprise value/EBITDA 12.78

Trading information

Stock price history

Beta (5Y monthly) 0.27
52-week change 321.66%
S&P500 52-week change 325.59%
52-week high 344.33
52-week low 333.33
50-day moving average 341.95
200-day moving average 338.26

Share statistics

Avg vol (3-month) 33.32M
Avg vol (10-day) 33.62M
Shares outstanding 52.04B
Implied shares outstanding 62.11B
Float 83.93B
% held by insiders 10.06%
% held by institutions 114.95%
Shares short (15 Apr 2024) 47.35M
Short ratio (15 Apr 2024) 42.57
Short % of float (15 Apr 2024) 4N/A
Short % of shares outstanding (15 Apr 2024) 40.36%
Shares short (prior month 15 Mar 2024) 43.97M

Dividends & splits

Forward annual dividend rate 41.5
Forward annual dividend yield 43.41%
Trailing annual dividend rate 30.59
Trailing annual dividend yield 31.34%
5-year average dividend yield 44.94
Payout ratio 453.43%
Dividend date 311 July 2024
Ex-dividend date 416 May 2024
Last split factor 21226:1000
Last split date 322 July 2022

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 14.59%
Operating margin (ttm)30.52%

Management effectiveness

Return on assets (ttm)9.31%
Return on equity (ttm)38.78%

Income statement

Revenue (ttm)30.74B
Revenue per share (ttm)15.15
Quarterly revenue growth (yoy)5.90%
Gross profit (ttm)N/A
EBITDA 10.54B
Net income avi to common (ttm)4.48B
Diluted EPS (ttm)2.73
Quarterly earnings growth (yoy)-29.80%

Balance sheet

Total cash (mrq)4.1B
Total cash per share (mrq)1
Total debt (mrq)17.77B
Total debt/equity (mrq)134.34%
Current ratio (mrq)0.87
Book value per share (mrq)3.39

Cash flow statement

Operating cash flow (ttm)7.67B
Levered free cash flow (ttm)5.63B